Skip to main content
NIH funding notice PAR-16-364

Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01)

Closed on January 24, 2018.

Posted
October 6, 2015
Close date
January 24, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $39,862,012 in first-year total cost, median $3,894,900.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-G (M2)]3
  2. Special Emphasis Panel[ZAG1 ZIJ-G (J1)]2
  3. Basic Neuroscience of Aging Study Section[NIA-N]1
  4. Special Emphasis Panel[ZAG1 ZIJ-G (M3)]1
  5. ZAG1-ZIJ-G(J1)1

Most frequent institutions

  1. AGENEBIO, INC.1
  2. BRIGHAM AND WOMEN'S HOSPITAL1
  3. JOHNS HOPKINS UNIVERSITY1
  4. UNIVERSITY OF FLORIDA1
  5. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PAR-16-364 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018DIAN-TU Primary Prevention Trial1U01AG059798-01MCDADE, ERIC MARTINWASHINGTON UNIVERSITY, MO$18,566,145ZAG1
2018Impact of challenging engagement on cognition in older adults: A clinical trial1R56AG058253-01PARK, DENISE CORTISUNIVERSITY OF TEXAS DALLAS, TX$1,266,382NIA
2017A Phase 3 pivotal trial of AGB101 to slow progression in MCI due to Alzheimer's Disease1R56AG055416-01MOHS, RICHARD CHARLESAGENEBIO, INC., MD$4,000,000ZAG1
2017Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial1R01AG055426-01CORESH, JOSEFLIN, FRANK RJOHNS HOPKINS UNIVERSITY, MD$3,789,799ZAG1
2017Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea1R01AG054435-01A1GOONERATNE, NALAKA SWOLK, DAVID AUNIVERSITY OF PENNSYLVANIA, PA$2,514,739ZAG1
2016Investigating Gains in Neurocognition in an Intervention Trial of Exercise1R01AG053952-01BURNS, JEFFREY MURRAYERICKSON, KIRK IKRAMER, ARTHUR F.MCAULEY, EDWARDUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$4,365,071ZAG1
2016The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease1R01AG054029-01AISEN, PAUL S.JOHNSON, KEITH A.SPERLING, REISA A.BRIGHAM AND WOMEN'S HOSPITAL, MA$4,020,661ZAG1
2016Augmenting Cognitive Training in Older Adults - The ACT Grant1R01AG054077-01COHEN, RONALD AMARSISKE, MICHAELWOODS, ADAM J.UNIVERSITY OF FLORIDA, FL$1,339,215ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-364: Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01) | ScienceDex | ConductScience